Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.085 USD | -1.12% | +1.66% | -33.26% |
Apr. 18 | NRx Pharmaceuticals Receives Notice of Listing Compliance From Nasdaq | MT |
Apr. 18 | Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Fed Policymakers Speeches | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.26% | 32.51M | |
+1.15% | 43.84B | |
+6.64% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.60% | 25.53B | |
-24.34% | 18.18B | |
-3.85% | 12.29B | |
+26.10% | 12.29B | |
+6.95% | 11.15B |
- Stock Market
- Equities
- BRPA Stock
- News NRx Pharmaceuticals, Inc.
- NRX Pharmaceuticals Contracts First Site for Phase 3 Clinical Trial of Investigational Bipolar Depression Treatment